CID: Analyzing efficacy and safety separately in clinical trials could yield misleading study conclusions if there's an increase in efficacy and a decrease in safety
IJTLD: Deshmukh and colleagues: High sensitivity and specificity of Xpert underscores need for rapid scale up for early detection of TB in settings with a high dual burden of TB and DM
Learn more about this effort to foster development of long-lasting therapies for illnesses that require taking medications long-term
The Consortium is chaired by Dr. Sonali Sarkar, Additional Professor, JIPMER on the Indian side and Dr. Amita Gupta, Professor, Johns Hopkins University, USA from the US side with oversight provided by DBT and NIH.
“AAIH’s mission dovetails very well with our own work at Hopkins,” CCGHE Director Dr. Robert Bollinger noted.
"TAP’s mission and approach meet a critical shortfall in patient care locally, and it’s an honor to be entrusted with strategic medical leadership for this effort."
CCGHE researchers and faculty will be in Hyderbad for the Union Conference--check out our agenda!
Study findings suggest that waiting until after delivery to start preventive therapy is associated with fewer adverse events
Researchers at Johns Hopkins and other institutions developed and tested a suite of mobile health applications that shows great promise for patient care and public health.